-
Why SpaceX IPO plan is generating so much buzz
-
Thailand continues Cambodia strikes despite Trump truce calls
-
US envoy to meet Zelensky, Europe leaders in Berlin this weekend
-
North Korea acknowledges its troops cleared mines for Russia
-
US unseals warrant for tanker seized off Venezuelan coast
-
Cambodia says Thailand still bombing hours after Trump truce call
-
Machado urges pressure so Maduro understands 'he has to go'
-
Best Gold Investment Companies in USA Announced (Augusta Precious Metals, Lear Capital, Robinhood IRA and More Ranked)
-
Leinster stutter before beating Leicester in Champions Cup
-
World stocks mostly slide, consolidating Fed-fuelled gains
-
Crypto firm Tether bids for Juventus, is quickly rebuffed
-
Union sink second-placed Leipzig to climb in Bundesliga
-
US Treasury lifts sanctions on Brazil Supreme Court justice
-
UK king shares 'good news' that cancer treatment will be reduced in 2026
-
Wembanyama expected to return for Spurs in NBA Cup clash with Thunder
-
Five takeaways from Luigi Mangione evidence hearings
-
UK's king shares 'good news' that cancer treatment will be reduced in 2026
-
Steelers' Watt undergoes surgery to repair collapsed lung
-
Iran detains Nobel-prize winner in 'brutal' arrest
-
NBA Cup goes from 'outside the box' idea to smash hit
-
UK health service battles 'super flu' outbreak
-
Can Venezuela survive US targeting its oil tankers?
-
Democrats release new cache of Epstein photos
-
Colombia's ELN guerrillas place communities in lockdown citing Trump 'intervention' threats
-
'Don't use them': Tanning beds triple skin cancer risk, study finds
-
Nancy aims to restore Celtic faith with Scottish League Cup final win
-
Argentina fly-half Albornoz signs for Toulon until 2030
-
Trump says Thailand, Cambodia have agreed to stop border clashes
-
Salah in Liverpool squad for Brighton after Slot talks - reports
-
Marseille coach tips Greenwood as 'potential Ballon d'Or'
-
Draw marks 'starting gun' toward 2026 World Cup, Vancouver says
-
Thai PM says asked Trump to press Cambodia on border truce
-
Salah admired from afar in his Egypt home village as club tensions swirl
-
World stocks retrench, consolidating Fed-fuelled gains
-
Brazil left calls protests over bid to cut Bolsonaro jail time
-
Trump attack on Europe migration 'disaster' masks toughening policies
-
US plan sees Ukraine joining EU in 2027, official tells AFP
-
'Chilling effect': Israel reforms raise press freedom fears
-
Iran frees child bride sentenced to death over husband's killing: activists
-
No doubting Man City boss Guardiola's passion says Toure
-
Youthful La Rochelle name teen captain for Champions Cup match in South Africa
-
World stocks consolidate Fed-fuelled gains
-
British 'Aga saga' author Joanna Trollope dies aged 82
-
Man Utd sweat on Africa Cup of Nations trio
-
EU agrees three-euro small parcel tax to tackle China flood
-
Taylor Swift breaks down in Eras documentary over Southport attack
-
Maresca 'relaxed' about Chelsea's rough patch
-
France updates net-zero plan, with fossil fuel phaseout
-
Nowhere to pray as logs choke flood-hit Indonesian mosque
-
In Pakistan, 'Eternal Love' has no place on YouTube
New Zealand approves medicinal use of 'magic mushrooms'
New Zealand on Wednesday approved the medicinal use of psilocybin, a hallucinogenic compound notably found in so-called "magic mushrooms".
Deputy Prime Minister David Seymour said rules had been relaxed so psilocybin could be used to treat certain types of depression.
Psilocybin is a naturally occurring psychedelic compound found in some species of mushroom and can cause hallucinations and an altered state of mind.
"Psilocybin remains an unapproved medicine, but a highly experienced psychiatrist has been granted authority to prescribe it to patients with treatment-resistant depression," Seymour said.
"This is huge for people with depression who've tried everything else and are still suffering.
"If a doctor believes psilocybin can help, they should have the tools to try."
There will be tight rules for prescribing the drug.
Only psychiatrists who have been involved in psilocybin clinical trials will be allowed to prescribe it, and they must strictly report its use and keep detailed records.
Party drugs such as as MDMA and magic mushrooms are increasingly being used in mainstream medical settings, helping treat post-traumatic stress disorder and depression.
Australia approved the medicinal use of psilocybin in 2023.
A.Malone--AMWN